Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
52
ZEPP Quote, Financials, Valuation and Earnings
Last price:
$28.22
Seasonality move
:
1.78%
Day range:
$27.70 - $28.50
52-week range:
$2.13 - $61.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.95x
P/B ratio:
3.70x
Volume:
166.2K
Avg. volume:
205.6K
1-year change:
848.32%
Market cap:
$410.1M
Revenue:
$182.7M
EPS (TTM):
-$4.11
Analysts' Opinion
-
Consensus RatingZepp Health Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $64.37, Zepp Health Corp. has an estimated upside of 125.54% from its current price of $28.26.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $64.37 representing 100% downside risk from its current price of $28.26.
Fair Value
-
According to the consensus of 1 analyst, Zepp Health Corp. has 125.54% upside to fair value with a price target of $64.37 per share.
ZEPP vs. S&P 500
-
Over the past 5 trading days, Zepp Health Corp. has underperformed the S&P 500 by -2.91% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Zepp Health Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Zepp Health Corp. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Zepp Health Corp. reported revenues of $75.9M.
Earnings Growth
-
Zepp Health Corp. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Zepp Health Corp. reported earnings per share of -$0.10.
Enterprise value:
516.8M
EV / Invested capital:
1.18x
Price / LTM sales:
1.95x
EV / EBIT:
--
EV / Revenue:
2.21x
PEG ratio (5yr expected):
-0.11x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$86.7M
Return On Assets:
-11.89%
Net Income Margin (TTM):
-28.24%
Return On Equity:
-26.32%
Return On Invested Capital:
-14.83%
Operating Margin:
-1.17%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $420.3M | $206.6M | $233.4M | $42.5M | $75.9M | |
| Gross Profit | $94.7M | $77.3M | $86.7M | $17.2M | $29M | |
| Operating Income | -$40.8M | -$37.7M | -$34.3M | -$12.5M | -$885.2K | |
| EBITDA | -$40M | -$32.8M | -- | -- | -$403.5K | |
| Diluted EPS | -$2.63 | -$2.48 | -$4.11 | -$0.82 | -$0.10 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $604.6M | $487.4M | $342.9M | $273.4M | $311.8M | |
| Total Assets | $943.4M | $820.9M | $661.7M | $588.8M | $586.4M | |
| Current Liabilities | $328.9M | $295.6M | $167.4M | $225.6M | $285.9M | |
| Total Liabilities | $493.6M | $428.4M | $314.5M | $273.3M | $360.1M | |
| Total Equity | $449.7M | $392.5M | $347.2M | $315.5M | $226.3M | |
| Total Debt | $125.3M | $102.8M | $120M | $43.5M | $70.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2015-12-31 | 2016-12-31 | 2017-12-31 | 2016-12-31 | 2017-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -$13.1M | |
| Cash From Investing | -- | -- | -- | -- | -$4.9M | |
| Cash From Financing | -- | -- | -- | -- | -$2.4M | |
| Free Cash Flow | -- | -- | -- | -- | -$14.1M | |
ZEPP
Sector
Market Cap
$410.1M
$52.8M
Price % of 52-Week High
46.14%
59.28%
Dividend Yield
0%
0%
Shareholder Yield
-0.77%
--
1-Year Price Total Return
894.43%
-14.26%
Beta (5-Year)
1.410
0.667
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$28.21
200-day SMA
Buy
Level
$21.58
Bollinger Bands (100)
Sell
Level
28.08 - 49.24
Chaikin Money Flow
Sell
Level
-1.8M
20-day SMA
Sell
Level
$28.37
Relative Strength Index (RSI14)
Sell
Level
46.46
ADX Line
Sell
Level
19.38
Williams %R
Neutral
Level
-47.2081
50-day SMA
Sell
Level
$32.79
MACD (12, 26)
Sell
Level
-0.87
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
20.8M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.3359)
Sell
CA Score
(Annual)
Level (-0.628)
Buy
Beneish M-Score
(Annual)
Level (-3.0058)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (1.313)
Sell
Piotroski F Score
(Annual)
Level (3)
Sell
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Zepp Health Corp. engages in the development of smart wearable health and consumer fitness devices. It empowers users to achieve their well-being goals by optimizing their health, fitness, and wellness journeys. Its brands include Amazfit, Zepp Clarity, and Zepp Aura. The company was founded by Huang Wang in 2013 and is headquartered in Gorinchem, Netherlands.
Stock Forecast FAQ
In the current month, ZEPP has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ZEPP average analyst price target in the past 3 months is $64.37.
-
Where Will Zepp Health Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Zepp Health Corp. share price will rise to $64.37 per share over the next 12 months.
-
What Do Analysts Say About Zepp Health Corp.?
Analysts are divided on their view about Zepp Health Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Zepp Health Corp. is a Sell and believe this share price will drop from its current level to $64.37.
-
What Is Zepp Health Corp.'s Price Target?
The price target for Zepp Health Corp. over the next 1-year time period is forecast to be $64.37 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ZEPP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Zepp Health Corp. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of ZEPP?
You can purchase shares of Zepp Health Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Zepp Health Corp. shares.
-
What Is The Zepp Health Corp. Share Price Today?
Zepp Health Corp. was last trading at $28.22 per share. This represents the most recent stock quote for Zepp Health Corp.. Yesterday, Zepp Health Corp. closed at $28.26 per share.
-
How To Buy Zepp Health Corp. Stock Online?
In order to purchase Zepp Health Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ZEPP Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ZEPP
Sector
P/E ratio
--
23.92x
PEG ratio
-0.11x
0.00x
P/B ratio
3.70x
2.10x
Price / LTM sales
1.95x
1.41x
Growth Metrics
ZEPP
Sector
Revenue growth
78.72%
6.61%
Earnings growth
87.54%
10.84%
Revenue (5-year growth)
-26.32%
4.95%
Earnings forecast
--
$0.13
Profitability
ZEPP
Sector
Profitability FY 2024
$70.3M
$29.8M
Return on invested capital
-14.83%
-0.62%
Return on assets
-11.89%
-1.32%
Return on equity
-26.32%
0.23%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Mar
18
Estimated Next Earnings Date
Feb
3
Balance Sheet
ZEPP
Sector
Total cash
$103.6M
$39.6M
Short term investments
$997K
$16.4M
Total assets
$528.6M
$158.9M
Long term debt
$70.8M
$4.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
